NCT04248023 is a NA clinical trial of Practice Facilitation in Alcohol Drinking, sponsored by Virginia Commonwealth University.

Who is sponsoring NCT04248023?

NCT04248023 is sponsored by Virginia Commonwealth University.

What drugs are being tested in NCT04248023?

Interventions in NCT04248023: Practice Facilitation.

What condition does NCT04248023 study?

NCT04248023 studies Alcohol Drinking, Alcohol Abuse, Alcohol Use Disorder.

Is NCT04248023 still recruiting?

NCT04248023 is currently completed. Last updated 25 July 2023.

Last reviewed 2023-07-25 · How we verify

NCT04248023

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Screening and Management of Unhealthy Alcohol Use in Primary Care

Completed NA Last updated 25 July 2023

What this trial tests

NA trial testing Practice Facilitation in Alcohol Drinking in 13,680 participants. Completed in 31 May 2023.

Timeline

15 July 2020

Primary endpoint
30 July 2022

31 May 2023

Quick facts

Lead sponsor	Virginia Commonwealth University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	screening
Enrollment	13,680
Start date	15 July 2020
Primary completion	30 July 2022
Estimated completion	31 May 2023
Sites	2 locations across United States

Drugs / interventions tested

Practice Facilitation

Conditions studied

Alcohol Drinking — all drugs for Alcohol Drinking →
Alcohol Abuse — all drugs for Alcohol Abuse →
Alcohol Use Disorder — all drugs for Alcohol Use Disorder →

Sponsor

Virginia Commonwealth University

Who can join

18 and older, any sex, with Alcohol Drinking or Alcohol Abuse. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Unhealthy alcohol use is the third leading preventable cause of death in the United States. Yet, primary care physicians do not, on average, screen for and address unhealthy alcohol use in their patient populations. By implementing practice changes to promote screening and treatment, patients stand to reduce unhealthy alcohol use and benefit from improved health outcomes. This project will provide a sample of Virginia primary care practices with a practice facilitator, practice specific resources, education on screening and counseling, and education on medication assisted therapy. The project will measure whether this change will improve screening rates and promote reduction of unhealthy alcohol use.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Practice facilitation to promote evidence-based screening and management of unhealthy alcohol use in primary care: a practice-level randomized controlled trial.
Huffstetler AN, Kuzel AJ, Sabo RT, Richards A, et al · · 2020 · cited 12× · PMID 32434467 · DOI 10.1186/s12875-020-01147-4
Practice Facilitation to Address Unhealthy Alcohol Use in Primary Care: A Cluster Randomized Clinical Trial.
Huffstetler AN, Villalobos G, Webel B, Rockwell MS, et al · · 2024 · cited 5× · PMID 39120895 · DOI 10.1001/jamahealthforum.2024.2371

Verify or expand the search:

Other trials of Practice Facilitation

Trials testing the same drug.

NCT06619782 — Practice Facilitation to Enhance Implementation of a Pediatric Suicide Prevention Pathway · NA · recruiting
NCT04755153 — Community Intervention to Reduce CardiovascuLar Disease in Chicago · NA · recruiting
NCT05241990 — Practice Facilitation as a Strategy to Improve Alcohol Treatment Adoption and Implementation in HIV Care · NA · recruiting
NCT05413252 — Team-based Care to Improve Hypertension · NA · active not recruiting
NCT05160233 — Digital Treatments for Opioids and Other Substance Use Disorders in Primary Care · NA · completed

Other recruiting trials for Alcohol Drinking

Currently open trials in the same condition.

NCT07415707 — The GLUCID Study: Effect of Alcohol Reduction and Probiotic Interventions on Cognition and Brain Glucose Metabolism in N · NA · recruiting
NCT06815237 — Effects of Ketone Supplement and Alcohol on Brain Metabolism · Phase 2, PHASE3 · recruiting
NCT06994962 — Multi-Component Breath Alcohol Intervention Phase 3 · NA · recruiting
NCT05363878 — Development of a Culturally Grounded, Trauma-Informed Alcohol Intervention With a Reserve-Dwelling First Nation Group · NA · recruiting
NCT06309134 — The Healthy Families Bright Futures Program · NA · recruiting

Other Virginia Commonwealth University trials

Trials by the same sponsor.

NCT05936931 — Young Adult-Mediated Intervention to Increase Colorectal Cancer Screening · NA · not yet recruiting
NCT07365839 — Cemiplimab +/- Fianlimab Post Y90 Radioembolization in Patients With Hepatocellular Carcinoma · Phase 1 · not yet recruiting
NCT07178158 — Enhancing Addiction Treatment Through Psychoeducation · NA · not yet recruiting
NCT07531316 — Safety and Tolerability Study of VVZ-2471 in Healthy Volunteers · Phase 1 · not yet recruiting
NCT07426913 — Cardiovascular Health Education Via Virtual Reality for Breast Cancer Survivors Receiving Anthracyclines or Trastuzumab · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04248023 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Virginia Commonwealth University
Last refreshed: 25 July 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04248023.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing